GLMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Galmed Pharmaceuticals Ltd (GLMD) is not a good buy for a beginner investor with a long-term investment strategy. The stock shows weak financial performance, no positive trading trends, no significant news catalysts, and bearish technical indicators. Additionally, the lack of trading signals from Intellectia Proprietary Trading Signals further supports avoiding this stock at the moment.
The technical indicators for GLMD are bearish. The MACD is slightly positive but contracting, RSI is neutral at 41.483, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 0.576), with resistance levels at R1: 0.658 and R2: 0.684. Overall, the technical outlook is weak.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Weak financial performance with declining net income (-1.15% YoY) and EPS (-84.85% YoY). The stock has a high probability of negative returns in the short term (-2.85% in the next week, -5.76% in the next month).
In Q3 2025, the company's revenue remained at 0 with no growth, net income dropped to -$1,892,000 (-1.15% YoY), and EPS declined significantly to -0.35 (-84.85% YoY). Gross margin was also 0, indicating no profitability.
No recent analyst ratings or price target changes available.
